top of page
Search Results
All (369)
Posts (276)
Other Pages (93)
Results found for "Lauren T May"
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
statistically significant reduction of symptoms, as assessed by PANSS total score, starting at Week 2 and maintained
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR),
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
modulated by a full agonist, BI167107, and a G-protein-biased partial agonist, salmeterol, involving mainly
- Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...
knockdown both depressed AMPAergic, inspiratory-related discharge activity of adult HMNs in vivo, which mainly
- Chronic itch: emerging treatments following new research concepts
Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are the main
- TLR4 biased small molecule modulators
Currently, attention was mainly paid to biased signaling modulators targeting G protein-coupled receptors
bottom of page